Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
MPLT: MapLight Therapeutics, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
MPLT
The Story
MPLT
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-51.8%
Financially safe
Stretched
Debt / equity
0.01×
Interest coverage
0.0×
Current ratio
22.91×
MapLight Therapeutics, Inc.
MPLT
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
MapLight Therapeutics, Inc.
MPLT
NASDAQ
·
USD
·
Closed
$13.02
−7.20%
$13.02
−$1.01 (7.20%)
52W Range
13th
pctl
Volume
1.70×
avg
Mkt Cap
10.28M
USD
P/E
-2.8
TTM
Div Yield
–
ann
52W Range
13th
pctl
Volume
1.70×
avg
Market Cap
10.28M
USD
P/E Ratio
-2.8
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings